Sign In
22 Feb 2018 13:00
22 February 2018
Collagen Solutions plc
("Collagen Solutions", the "Company" or the "Group")
Director/PDMR Shareholding
The Company today announces that on 21 February 2018 the following share purchases were made. Malcolm Gillies, Non-Executive Director, purchased 500,000 ordinary shares of 1p each in the capital of the Company ("Ordinary Shares") at a purchase price of 3.30p per Ordinary Share; and Hilary Spence, Chief Financial Officer, purchased 30,817 Ordinary Shares at a purchase price of 3.18p.
Following these purchases, Malcolm Gillies holds 4,153,000 Ordinary Shares representing approximately 1.28 per cent of the Company's issued share capital; and Hilary Spence holds 30,817 Ordinary Shares representing approximately 0.01 per cent of the Company's issued share capital.
The Company makes the following disclosures in accordance with article 19(3) of the Market Abuse Regulation:
1
| Details of the person discharging managerial responsibilities / person closely associated
| |||||
a)
| Name
| Malcolm Gillies
| ||||
2
| Reason for the notification
| |||||
a)
| Position/status
| Non-Executive Director
| ||||
b)
| Initial notification /Amendment
| Initial | ||||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||
a)
| Name
| COLLAGEN SOLUTIONS PLC | ||||
b)
| LEI
| 213800IFY1CVGRGETL95 | ||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||
a)
| Description of the financial instrument, type of instrument
Identification code
| Ordinary Shares of 1p each
ISIN: GB00B94T6Y14
| ||||
b)
| Nature of the transaction
| Purchase of Ordinary Shares | ||||
c)
| Price(s) and volume(s)
|
| ||||
d)
| Aggregated information
- Aggregated volume
- Price
|
N/A - single transaction
| ||||
e)
| Date of the transaction
| 21 February 2018 | ||||
f)
| Place of the transaction
| London Stock Exchange, XLON | ||||
1
| Details of the person discharging managerial responsibilities / person closely associated
| |||||
a)
| Name
| Hilary Spence | ||||
2
| Reason for the notification
| |||||
a)
| Position/status
| Chief Financial Officer | ||||
b)
| Initial notification /Amendment
| Initial | ||||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||
a)
| Name
| COLLAGEN SOLUTIONS PLC | ||||
b)
| LEI
| 213800IFY1CVGRGETL95 | ||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||
a)
| Description of the financial instrument, type of instrument
Identification code
| Ordinary Shares of 1p each
ISIN: GB00B94T6Y14
| ||||
b)
| Nature of the transaction
| Purchase of Ordinary Shares | ||||
c)
| Price(s) and volume(s)
|
| ||||
d)
| Aggregated information
- Aggregated volume
- Price
|
N/A - single transaction
| ||||
e)
| Date of the transaction
| 21 February 2018 | ||||
f)
| Place of the transaction
| London Stock Exchange, XLON | ||||
For further information please contact:
Collagen Solutions PlcJamal Rushdy, Chief Executive OfficerHilary Spence, Chief Financial OfficerLisa Baderoon, Head of Investor Relations | Tel: +44 (0) 141 648 9100Tel: +44 (0) 7721 413 496 or lisa.baderoon@collagensolutions.com |
Cenkos Securities plc (NOMAD and Broker)Stephen KeysSteve Cox | Tel: +44 (0) 207 397 8900 |
Walbrook PRAnna DunphyHelen Cresswell | Tel: +44 (0) 20 7933 8780 or collagen@walbrookpr.comMob: +44 (0) 7876 741 001 |
Follow the stocks
